![Dikla Akselbrad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 801 $ al 31/08/2026
Dikla Czaczkes Akselbrad currently works at PolyPid Ltd., as Chief Executive Officer & Director from 2022.
Ms. Akselbrad also formerly worked at Compugen Ltd., as Chief Financial Officer from 2008 to 2014, Ernst & Young (Israel) Ltd., as Audit Manager from 1997 to 2000, and Packet Technologies Ltd., as Chief Financial Officer from 2000 to 2002.
Ms. Akselbrad received her undergraduate degree and Masters Business Admin degree from Tel-Aviv University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
POLYPID LTD. 0,01 % | 15/07/2026 | 934 ( 0,01 % ) | 4 801 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| POLYPID LTD. | Director Ejecutivo | 01/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| COMPUGEN LTD. | Director Financiero/CFO | 01/05/2014 |
Packet Technologies Ltd. | Director Financiero/CFO | 01/01/2002 |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Comptroller/Controller/Auditor | 01/01/2000 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young (Israel) Ltd.
Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
PolyPid Ltd.
 PolyPid Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage specialty pharmaceutical company that is engaged in developing of product candidates based on polymer-lipid encapsulation matrix technology | Health Technology |
Packet Technologies Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
